Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SOD1 | P00441 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | FLT1 | P17948 | 2/20 | 0.36 |
| ▸ | FLT4 | P35916 | 2/20 | 0.36 |
| ▸ | KDR | P35968 | 2/20 | 0.36 |
| ▸ | S100A9 | P06702 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20241140 | 0.97 | TSHR (0.44) | TSHRALDH1A1HSD17B10TDP1SOD1 | |
| SCHEMBL1320308 | 0.83 | ACLY (0.39) | TSHRALDH1A1HSD17B10TDP1SOD1 | |
| SCHEMBL2055455 | 0.83 | FFAR4 (0.39) | ALDH1A1HSD17B10TDP1ACLYPGR | |
| SCHEMBL13905714 | 0.83 | CYP3A4 (0.52) | TSHRALDH1A1HSD17B10TDP1CYP3A4 | |
| SCHEMBL2055456 | 0.83 | ACLY (0.38) | ALDH1A1HSD17B10TDP1ACLYPSEN1 | |
| Hydrochloric Acid SCHEMBL7571169 | 0.82 | FBP1 (0.47) | ALDH1A1HSD17B10TDP1PGR | |
| 1,3,5-Trichlorobenzene SCHEMBL4216819 | 0.81 | TSHR (0.61) | TSHRALDH1A1HSD17B10SOD1ACLY | |
| SCHEMBL218559 | 0.81 | ALDH1A1 (0.53) | ALDH1A1HSD17B10TDP1CYP3A4MAPK1 | |
| SCHEMBL1958683 | 0.79 | ALDH1A1 (0.52) | TSHRALDH1A1HSD17B10SOD1ACLY | |
| SCHEMBL2852652 | 0.78 | FFAR4 (0.42) | ALDH1A1CYP3A4TP53PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 925 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119425423-A | Positively charged composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2013102936-A1 | N-(3-((DIETHYLAMINO) METHYL)-4-HYDROXYPHENYL)-N-(QUINOLIN-4-YL) SULFONAMIDES FOR THE TREATMENT OF TUBERCULOSIS AND PROCESS OF PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-07-11 | — | — | WO | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| CN-121202849-B | Coumarin-pyrazole ring hybridization derivative and preparation method and application thereof | NORTHWEST UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| WO-2026107406-A1 | p53 HETEROBIFUNCTIONAL CONJUGATES AND USES THEREOF | Design Therapeutics, Inc. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12630548-B2 | Azetidine derivatives for the treatment of integrin associated diseases | THE UNIVERSITY OF NOTTINGHAM (GB) | 2026-05-19 | — | — | US | disclosed |
| US-12630529-B2 | GCN2 modulator compounds | Alesta Therapeutics BV (NL) | 2026-05-19 | — | — | US | disclosed |
| US-20250381168-A1 | VLA4 INHIBITORS AND USES THEREOF | WASHINGTON UNIVERSITY ST LOUIS (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250339388-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250319046-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4631947-A1 | SUBSTITUTED TRICYCLIC LIGANDS FOR FK506-BINDING PROTEINS FOR TREATMENT OF DISEASES | Technische Universität Darmstadt (DE) | 2025-10-15 | — | — | EP | disclosed |
| EP-0511826-B1 | Phosphosulfonate herbicides | ROHM & HAAS (US) | 1997-07-16 | — | — | EP | disclosed |
| US-5500405-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| US-5272128-A | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0468323-B1 | IMPROVED MICROCAPSULES | BAYER AG (DE) | 1993-09-08 | — | — | EP | disclosed |
| EP-0511826-A2 | Phosphosulfonate herbicides | ROHM AND HAAS COMPANY (US) | 1992-11-04 | — | — | EP | disclosed |
| EP-0468323-A1 | Improved microcapsules | BAYER AG (DE) | 1992-01-29 | — | — | EP | disclosed |
| US-4802910-A | Herbicidal acylated sulphonylguanidines | BAYER AKTIENGESELLSCHAFT (DE) | 1989-02-07 | — | — | US | disclosed |
| US-4097669-A | FUNGICIDES, BACTERICIDES, INSECTICIDES, ARTHROPODICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |
| US-3983300-A | POLYAROMATIC SULFONE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630529-B2 | GCN2 modulator compounds | NR3C1, GCN1, EIF2AK4 | TSHR 1115/4885ALDH1A1 4260/4885HSD17B10 733/4885 |
| US-20250339388-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | SLC43A1, SLC7A1, SLC1A5 | TSHR 3378/4885ALDH1A1 2745/4885HSD17B10 2654/4885 |
| US-12630548-B2 | Azetidine derivatives for the treatment of integrin associated diseases | ITGA2, ITGB2, ITGB1 | TSHR 104/4885ALDH1A1 814/4885HSD17B10 3114/4885 |
| US-20250319046-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | SLC43A1, SLC7A1, SLC1A5 | TSHR 3378/4885ALDH1A1 2745/4885HSD17B10 2654/4885 |
| US-20250381168-A1 | VLA4 INHIBITORS AND USES THEREOF | CXCR4, SDF4, ITGB4 | TSHR 2581/4885ALDH1A1 523/4885HSD17B10 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.